Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Cheung NK, Modak S, Lin Y, Guo H, Zanzonico P, Chung J, Zuo Y, Sanderson J, Wilbert S, Theodore LJ, Axworthy DB, Larson SM.

J Nucl Med. 2004 May;45(5):867-77.

2.

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

Graves SS, Dearstyne E, Lin Y, Zuo Y, Sanderson J, Schultz J, Pantalias A, Gray D, Axworthy D, Jones HM, Auditore-Hargreaves K.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3712-21.

Supplemental Content

Loading ...
Support Center